Inhibiting ERp29 expression enhances radiosensitivity in human nasopharyngeal carcinoma cell lines Lin QiPing WuYongquan Tian Original Paper 11 April 2011 Pages: 721 - 728
DAPK promoter hypermethylation in tissues and body fluids of oral precancer patients Yang LiuZeng-Tong ZhouWei-Wen Jiang Original Paper 24 April 2011 Pages: 729 - 733
Prognostic value of oncoprotein expressions in thyroid papillary carcinoma A. Z. BaltaA. I. FilizM. L. Akin Original Paper 06 May 2011 Pages: 734 - 741
Prognostic significance of galectin-3 and cyclin D1 expression in undifferentiated nasopharyngeal carcinoma Mustafa Fuat AcikalinDurmus EtizErtugrul Colak Original Paper 07 May 2011 Pages: 742 - 749
Sequential treatment with sorafenib and sunitinib in metastatic renal cell carcinoma: clinical outcomes from a retrospective clinical study Loukas KontovinisKonstantinos LaschosKonstantinos Papazisis Original Paper 30 January 2011 Pages: 750 - 754
Accuracy of GFR estimation by the Cockroft and Gault, MDRD, and Wright equations in Oncology patients with renal impairment O. O. FaluyiS. P. MasingheS. Clive Original Paper 01 February 2011 Pages: 755 - 760
A phase II trial of doxorubicin and gemcitabine in renal cell carcinoma with sarcomatoid features: ECOG 8802 Naomi B. HaasXinyi LinJanice Dutcher Original Paper 06 February 2011 Pages: 761 - 767
Radiation-induced chronic oxidative renal damage can be reduced by amifostine Rusen CosarVuslat Yurut-CalogluZafer Kocak Original Paper 24 February 2011 Pages: 768 - 775
Second-line chemotherapy in metastatic docetaxel-resistant prostate cancer: a review Giuseppe CollocaAntonella VenturinoFranco Checcaglini Review 20 February 2011 Pages: 776 - 785
Safety and treatment patterns of angiogenesis inhibitors in patients with metastatic renal cell carcinoma: evidence from US community oncology clinics Bruce A. FeinbergPradeep JollyMei Sheng Duh Original Paper 09 April 2011 Pages: 786 - 794
Temsirolimus in renal cell carcinoma with sarcomatoid differentiation: a report of three cases Maria Carmen AresesUrbano Anido HerranzRafael López López Case Report 11 May 2011 Pages: 795 - 798
Pioglitazone, etoricoxib, interferon-α, and metronomic capecitabine for metastatic renal cell carcinoma: final results of a prospective phase II trial B. WalterI. SchrettenbrunnerA. Reichle Original Paper 24 May 2011 Pages: 799 - 805
Durable remission of leptomeningeal metastases from hormone-responsive prostate cancer Meng ZhangAli MahtaSantosh Kesari Case Report 20 March 2011 Pages: 806 - 808
Systemic alterations in concentrations and distribution of plasma phospholipids in prostate cancer patients B. CvetkovićV. VučićM. Glibetić Original Paper 26 March 2011 Pages: 809 - 814
MiR-221 expression affects invasion potential of human prostate carcinoma cell lines by targeting DVL2 Chang ZhengSun YinghaoJiao Li Original Paper 13 April 2011 Pages: 815 - 822
Prostate-specific antigen: its relationship with alcohol intake and tobacco Jorge D. Escandriolo NackauziRaúl H. CollaAdriana B. Actis Original Paper 12 April 2011 Pages: 823 - 826
Small cell carcinoma of the urinary bladder with hypercalcemia Mehmet Ali Nahit ŞendurSercan AksoyNurullah Zengin Letter To The Editor 17 April 2011 Pages: 827 - 828
Implications of transcriptional factor, OCT-4, in human bladder malignancy and tumor recurrence Peng HuangJie ChenHiromi Kumon Original Paper 01 May 2011 Pages: 829 - 834
Differentiated prostatic antigen expression in LNCaP cells following treatment with bispecific antisense oligonucleotides directed against BCL-2 and EGFR Marvin RubensteinCourtney M. P. HollowellPatrick Guinan Original Paper 15 May 2011 Pages: 835 - 841
UHRF1 is associated with tumor recurrence in non-muscle-invasive bladder cancer Guo-Liang YangLian-Hua ZhangYi-Ran Huang Original Paper 25 May 2011 Pages: 842 - 847
Meat intake and risk of bladder cancer: a meta-analysis Chaojun WangHai Jiang Original Paper 24 May 2011 Pages: 848 - 855
miR-107 targets cyclin-dependent kinase 6 expression, induces cell cycle G1 arrest and inhibits invasion in gastric cancer cells Li FengYun XieYunlin Wu Original Paper 25 January 2011 Pages: 856 - 863
Clinicopathologic features and prognosis analysis of mucinous gastric carcinoma Chunming YinDeming LiHuimian Xu Original Paper 05 February 2011 Pages: 864 - 870
The overexpression of AP-4 as a prognostic indicator for gastric carcinoma Liu XinghuaZhang BoChen Jianying Original Paper 20 February 2011 Pages: 871 - 877
Overexpression of Nanog protein is associated with poor prognosis in gastric adenocarcinoma Ting LinYan-Qing DingJian-Ming Li Original Paper 20 February 2011 Pages: 878 - 885
MicroRNA-146a is down-regulated in gastric cancer and regulates cell proliferation and apoptosis Zhibo HouLi XieBaorui Liu Original Paper 24 February 2011 Pages: 886 - 892
Telomere shortening occurs early during gastrocarcinogenesis Yunchuan MuQing ZhangJiren Yu Original Paper 27 February 2011 Pages: 893 - 898
The analysis of CD45 isoforms expression on HBV-specific T cells after liver transplantation Lelin PanWenjin ZhangShusen Zheng Original Paper 30 January 2011 Pages: 899 - 908
Reduced survival of patients with hepatocellular carcinoma expressing hexokinase II Lei GongZhuqingqing CuiXisheng Leng Original Paper 30 January 2011 Pages: 909 - 914
Correlation between T-cadherin gene expression and aberrant methylation of T-cadherin promoter in human colon carcinoma cells Jian-zhen RenJi-rong Huo Original Paper 05 February 2011 Pages: 915 - 918
Downregulation of miR-195 correlates with lymph node metastasis and poor prognosis in colorectal cancer Xueqing WangJiandong WangXiaojun Zhou Original Paper 10 March 2011 Pages: 919 - 927
The correlation between IGF-II and Bcl-2 expression in colorectal adenocarcinoma Ming-Sheng ZhangAi-Hua HuYuan Chen Original Paper 06 March 2011 Pages: 928 - 932
Analysis of HER2 gene amplification and protein expression in esophageal squamous cell carcinoma Na ZhanWei-Guo DongCheng-long Xiong Original Paper 13 February 2011 Pages: 933 - 940
Surgical outcomes of gastrointestinal stromal tumors of the stomach: a single unit experience in the era of targeted drug therapy Hai HuangHan LiangXi-Shan Hao Original Paper 09 March 2011 Pages: 941 - 947
PTP1B expression contributes to gastric cancer progression Jinguo WangBingya LiuZhenggang Zhu Original Paper 27 March 2011 Pages: 948 - 956
Multidisciplinary treatment with chemotherapy, targeted drug, and high-intensity focused ultrasound in advanced pancreatic carcinoma Ying YuanHong ShenXian Zhong Case Report 09 March 2011 Pages: 957 - 961
Apoptosis in esophagus and pancreas carcinoma cells induced by circulating microparticles is related to phosphatidyl serine and microparticle-associated caspases Jan SchneiderAnsgar M. ChromikDaniel Bulut Original Paper 31 March 2011 Pages: 962 - 969
Clinical implications of mismatched repair gene promoter methylation in pancreatic cancer M. LiZ. W. Zhao Original Paper 10 June 2011 Pages: 970 - 976
Caveolin-1 is related to invasion, survival, and poor prognosis in hepatocellular cancer Yu TangXiangtian ZengMasakazu Toi Original Paper 17 March 2011 Pages: 977 - 984
O-GlcNAcylation plays a role in tumor recurrence of hepatocellular carcinoma following liver transplantation Qianqian ZhuLin ZhouShusen Zheng Original Paper 03 April 2011 Pages: 985 - 993
MAGE-3 and MAGE-4 genes as possible markers for early detection of metastases in hepatitis C virus Egyptian patients complicated by hepatocellular carcinoma Yousri M. HusseinAmal F. GhareibWael H. Elsawy Original Paper 31 March 2011 Pages: 994 - 999
Effect of short hairpin RNA of Bcl-xL gene on biological behaviors of HepG-2 cells Duan MengxiYuan HongJiang Yanmei Original Paper 29 April 2011 Pages: 1000 - 1004
A decline in weight and attrition of muscle in colorectal cancer patients receiving chemotherapy with bevacizumab Timothy PoteruchaBrian BurnetteAminah Jatoi Short Communication 12 March 2011 Pages: 1005 - 1009
Prognostic value of hedgehog signaling pathway in patients with colon cancer Meihua XuXinhua LiGuiying Zhang Original Paper 19 March 2011 Pages: 1010 - 1016
Refractory generalized seizures as a possible side effect of bevacizumab in a colon cancer patient Veli BerkSevda IsmailogullariMetin Ozkan Case Report 02 April 2011 Pages: 1017 - 1019
5-Fluorouracil or capecitabine in the treatment of advanced colorectal cancer: a pooled-analysis of randomized trials Fausto PetrelliMary CabidduSandro Barni Review Article 24 April 2011 Pages: 1020 - 1029
Carbohydrate antigen 242 highly consists with carbohydrate antigen 19-9 in diagnosis and prognosis of colorectal cancer: study on 185 cases Xue-Qin YangChuang ChenYan Li Original Paper 07 May 2011 Pages: 1030 - 1036
MicroRNA-9 up-regulation is involved in colorectal cancer metastasis via promoting cell motility Liang ZhuHuarong ChenWeiting Ge Original Paper 12 May 2011 Pages: 1037 - 1043
Effect of rs6983267 polymorphism in the 8q24 region and rs4444903 polymorphism in EGF gene on the risk of sporadic colorectal cancer in Iranian population A. DaraeiR. SalehiH. Tavakoli Original Paper 13 May 2011 Pages: 1044 - 1049
Erratum to: Effect of rs6983267 polymorphism in the 8q24 region and rs4444903 polymorphism in EGF gene on the risk of sporadic colorectal cancer in Iranian population A. DaraeiR. SalehiH. Tavakoli Erratum 12 August 2011 Pages: 1050 - 1050